Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carfilzomib + thalidomide + dexamethasone for induction and consolidation in newly diagnosed multiple myeloma
2009-014922-40Phase 2Active
- Sponsor
- Erasmus MC
- Start
- Jan 2010
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of carfilzomib in multiple myeloma (MM), sponsored by Erasmus MC. Started Jan 2010; status: active.
02
Drugs
carfilzomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2009-014922-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014922-40.